SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-098992
Filing Date
2023-04-12
Accepted
2023-04-12 13:51:56
Documents
2
Group Members
ANDREW M. WEISS PH.D.BIP GP LLCWAM GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d384343dsc13d.htm SC 13D 47652
2 EX-99.1 d384343dex991.htm EX-99.1 6569
  Complete submission text file 0001193125-23-098992.txt   55920
Mailing Address 222 BERKELEY STREET, 16TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 16TH FLOOR BOSTON MA 02116 617-778-7780
Weiss Asset Management LP (Filed by) CIK: 0001357550 (see all company filings)

IRS No.: 611451623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88552 | Film No.: 23815333
SIC: 2834 Pharmaceutical Preparations